Freenome Holdings, Inc.
Overview
Freenome Holdings, Inc. is a biotechnology company focused on developing and deploying early detection blood tests for cancer through the use of machine learning and advanced multiomics. The company's mission is to enable proactive treatment and better outcomes by detecting cancer at an early and manageable stage.
Therapeutic areas
OncologyDiagnostics
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Freenome Holdings, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Becton, Dickinson and Company
United States
ColoSTAT Biotech Inc.
United States
InterVenn Biosciences Inc.
United States
OPKO Health, Inc.
United States
Pharmalucence Inc.
United States
Ventana Medical Systems, Inc.
United States
Rhythm Biosciences Limited
Australia
3D Imaging Drug Design and Development LLC
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.